LCP1 and renal cell carcinoma: A composite three marker assay [based on nicotinamide N-methyltransferase (NNMT), L-plastin (LCP1) and non-metastatic cells 1 protein (NM23A)] was developed and had 90% sensitivity, 95.7% specificity and diagnostic AUC 0.932 for RCC versus healthy controls.